Shanghai Fosun Pharmaceutical Group Co Ltd
Fosun Pharma's GHG Emissions Data Preview
In 2023, Fosun Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
However, Fosun Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Fosun Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Fosun Pharma amounted to 888,693 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Fosun Pharma decreased by 6.32%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Fosun Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Fosun Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Fosun Pharma were 210,819 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Fosun Pharma reduced its Scope 1 emissions over time?
Since 2018, Fosun Pharma's Scope 1 emissions have decreased by 46.77%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Fosun Pharma's Scope 1 emissions decreased by 27.06%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Fosun Pharma's Scope 2 emissions?
In 2023, Fosun Pharma reported Scope 2 greenhouse gas (GHG) emissions of 677,874 tCOâ‚‚e without specifying the calculation method.
Has Fosun Pharma reduced its Scope 2 emissions over time?
Since 2018, Fosun Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 74.14%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Fosun Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Fosun Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Fosun Pharma use for Scope 2 reporting?
In 2023, Fosun Pharma reported its Scope 2 emissions using an unspecified methodology.
Fosun Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Fosun Pharma's Value Chain Emissions
In 2023, Fosun Pharma reported 72,171 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Fosun Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Fosun Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Fosun Pharma's Scope 3 emissions?
In 2023, Fosun Pharma reported total Scope 3 emissions of 72,171 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Fosun Pharma reduced its Scope 3 emissions over time?
Since 2018, Fosun Pharma's Scope 3 emissions have increased by 6,812.93%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), Fosun Pharma's Scope 3 emissions increased by 8,989.55%, suggesting that the company faced challenges in reducing emissions across its value chain.
Insights into Fosun Pharma's Total Carbon Footprint
In 2023, Fosun Pharma reported a total carbon footprint of 960,864 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1.2% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Fosun Pharma's total carbon footprint was Scope 2 emissions, accounting for 70.55% of the company's total carbon footprint, followed by Scope 1 emissions at 21.94%.